Back to Results
First PageMeta Content
Diarrhea / Antibiotic-resistant bacteria / Clostridium difficile / Gram-positive bacteria / Gut flora / Eli Lilly and Company / Fidaxomicin / Antibiotic resistance / Vancomycin / Medicine / Microbiology / Biology


European Medicines Agency recommends authorisation of first-in-class antibiotic for C. difficile
Add to Reading List

Document Date: 2013-07-21 06:20:11

Open Document

File Size: 56,90 KB

Share Result on Facebook

City

London / /

Company

Press Office Press / /

Country

United Kingdom / /

Currency

EUR / /

/

Facility

Canary Wharf / /

MedicalCondition

vomiting / disease / headache / stomach cramps / infectious diseases / Infection / inflammation / illness / C. difficile infection / infections / /

MedicalTreatment

antibiotics / /

Organization

Committee for Medicinal Products for Human Use / European Union / European Medicines Agency / Website www.ema.europa.eu An / European Commission / /

Person

Xavier Luria / Monika Benstetter / Sabine Haubenreisser / /

/

Position

Head / /

Product

metronidazole / /

URL

www.ema.europa.eu / /

SocialTag